Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | PRKDC | P78527 | 3/20 | 0.42 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 10/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30186865 | 0.99 | ALOX5 (0.57) | ALOX5PRKDCPARP14PDK2MAPT | |
| SCHEMBL16110376 | 0.99 | ALOX5 (0.57) | ALOX5PRKDCPARP14PDK2MAPT | |
| SCHEMBL17692347 | 0.97 | ALOX5 (0.53) | ALOX5PRKDCPARP14PDK2MAPT | |
| SCHEMBL15893247 | 0.96 | ALOX5 (0.51) | ALOX5PRKDCPARP14PDK2MAPT | |
| SCHEMBL14101660 | 0.96 | ALOX5 (0.59) | ALOX5PRKDCPARP14PDK2MAPT | |
| SCHEMBL17167387 | 0.95 | ALOX5 (0.51) | ALOX5PRKDCPARP14PDK2MAPT | |
| SCHEMBL17692378 | 0.95 | ALOX5 (0.51) | ALOX5PRKDCPARP14PDK2MAPT | |
| SCHEMBL17692371 | 0.94 | ALOX5 (0.50) | ALOX5PRKDCPARP14PDK2MAPT | |
| SCHEMBL18826103 | 0.93 | ALOX5 (0.49) | ALOX5PRKDCPARP14PDK2MAPT | |
| SCHEMBL15857002 | 0.93 | ALOX5 (0.49) | ALOX5PRKDCPARP14PDK2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10038152-B2 | Organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2018-07-31 | — | — | US | disclosed |
| US-10038152-B2 | Organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2018-07-31 | — | — | US | disclosed |
| US-9899613-B2 | Organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2018-02-20 | — | — | US | disclosed |
| US-9899613-B2 | Organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2018-02-20 | — | — | US | disclosed |
| US-20150372244-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-24 | — | — | US | disclosed |
| US-20150372244-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-24 | — | — | US | disclosed |
| US-20150357586-A1 | ORGANIC LIGHT-EMITTING ELEMENT | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-10 | — | — | US | disclosed |
| US-20150357586-A1 | ORGANIC LIGHT-EMITTING ELEMENT | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-10 | — | — | US | disclosed |
| US-20150295188-A1 | ORGANIC LIGHT-EMITTING ELEMENT | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-10-15 | — | — | US | disclosed |
| US-20150295188-A1 | ORGANIC LIGHT-EMITTING ELEMENT | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10038152-B2 | Organic light-emitting element | NFE2L2, EML4, LEF1 | ALOX5 1144/4885PRKDC 4155/4885PARP14 2044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.